Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.
Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Granules shares
The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.
AI Appreciation Day 2025: Experts Speak On The Transformative Power Of Generative AI
Uttar Pradesh News: Lucknow Hosts Kaushal Mela 2025 On World Youth Skills Day To Promote Vocational Training And Self-Reliance
Uttar Pradesh News: Agra Municipal Corporation Launches Door-To-Door House Tax Drive, Plans Re-Survey Of Commercial Properties
Uttar Pradesh News: Varanasi Land Dispute Triggers Rajbhar-Thakur Caste Clash Amid Political Interference In Chitauna Village
